Redesign Health, a global venture and applied technology firm, has announced its deeper expansion into India, partnering with healthcare-focused investment firm Sky Impact Capital to back next-generation healthcare artificial intelligence (AI) companies. The firm plans to invest in and partner with founders building healthcare AI solutions for both Indian and global markets. It is also raising a dedicated investment vehicle to support early-stage healthcare AI companies in India, with a focus on pre-seed and ideation-stage founders.
India as a Key Market for Healthcare AI
Redesign Health's expansion reflects its conviction that India is one of the best markets in the world for building and investing in healthcare AI. The country combines a large and rapidly growing healthcare market, digital infrastructure that enables rapid scaling, world-class healthcare incumbents for partnership, and a deep pool of technical talent. According to Brett Shaheen, Founder and CEO of Redesign Health, "India represents one of the most important opportunities in global healthcare and AI. The combination of engineering talent, clinical need, and system complexity creates the conditions to build solutions that are both locally transformative and globally relevant."
Partnership with Sky Impact Capital
Redesign Health has partnered with Sky Impact Capital, an operationally oriented investment firm that has impacted millions of lives since its inception in 2018. Aakash Sachdev, Founder & Managing Partner of Sky Impact Capital and Co-Founder & General Partner of Redesign Health India, stated, "We are excited to partner with Redesign Health, whose proven model brings a differentiated capability to the Indian market and is the right model to capitalize on India's advantages to create and capture value in healthcare." Through this partnership, the firms aim to work with exceptional founders, leverage technology to expand access and improve outcomes, and build leading healthcare companies for India and from India for the world.
Founder Support and Market Ambition
Over the past several months, Redesign Health has spoken with more than a hundred healthcare and AI founders across India. Adam Jones, Managing Director at Redesign Health, noted, "What stands out is their ambition not only to improve healthcare outcomes in India, but to build companies with the potential to shape healthcare globally." Redesign Health's model is designed to support founders from ideation through exit, an area where structured support is still limited in India, particularly for healthcare-focused companies. Through its platform, Redesign Health will partner with founders at the pre-seed and concept stage to refine concepts, navigate regulatory and commercialization pathways, provide product and go-to-market expertise, and support companies in building for both Indian and global markets to achieve venture-scale outcomes.
Impact on India's Healthcare System
Beyond company creation, Redesign Health's expansion is focused on contributing to the evolution of India's healthcare system. AI-enabled solutions developed in India have the potential to expand access to care across underserved populations, improve early detection and disease management, increase system efficiency in high-demand environments, and create new models for delivering care at scale. Redesign plans to work closely with healthcare providers, partners, and policymakers to support the responsible development and deployment of these technologies.
Immediate Steps and Future Updates
With a team of investors and operators already established in India, Redesign Health is accelerating its buildout, expanding its local team, advancing development partnerships, and progressing a pipeline of early-stage investment opportunities. Further updates, including initial company launches and strategic partnerships, are expected in the coming months. The firm's presence spans India, the Middle East, and the United States, positioning it to help entrepreneurs navigate the challenges of building and scaling global healthcare businesses.
